©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report
Yutaka Yano, Esteban C Gabazza, Corina N D'Alessandro-Gabazza, Toshinari Suzuki, Mei Uemura, Akihiro Uchida, Kanako Maki, Chisa Inoue, Kazuhito Eguchi, Kota Nishihama, Soichiro Tanaka, Yuko Okano, Taro Yasuma
Taro Yasuma, Yuko Okano, Department of Diabetes, Metabolism, and Endocrinology and Immunology, Mie University, Tsu 514-8507, Japan
Soichiro Tanaka, Kota Nishihama, Kazuhito Eguchi, Chisa Inoue, Kanako Maki, Akihiro Uchida, Mei Uemura, Toshinari Suzuki, Department of Diabetes, Metabolism, and Endocrinology, Mie University, Tsu 514-8507, Japan
Corina N D'Alessandro-Gabazza, Department of Immunology, Mie University School of Medicine, Mie University, Tsu 514-8507, Japan
Esteban C Gabazza, Department of Immunology, Mie University Faculty and Graduate School of Medicine, Tsu 514-8507, Japan
Yutaka Yano, Department of Diabetes, Mie University Graduate School of Medicine, Tsu 514-8507, Japan
Author contributions: Yasuma T, Tanaka S, and Nishihama K were responsible for clinical treatment and clinical follow-up; Yasuma T prepared the first draft of the manuscript; Eguchi KC, Inoue CC, Maki KC, Okano Y, and Uchida A contributed with resources and acquisition of data; Suzuki T, D'Alessandro-Gabazza CN, Yano Y, and Gabazza EC contributed to the interpretation of the data and made an intellectual contribution to the manuscript's preparation.
Informed consent statement: Written informed consent was obtained from the patient to publish clinical details and images when she was alive.
Conflict-of-interest statement: Yano Y reports receiving lecture fees from Novo Nordisk; and Gabazza EC received grants from Shionogi Corporation and Asahi Kasei. Other authors declared no conflict of interest concerning this case report.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Esteban C Gabazza, MD, PhD, Director, Full Professor, Department of Immunology, Mie University Faculty and Graduate School of Medicine, Edobashi 2-174, Tsu 514-8507, Japan.
gabazza@doc.medic.mie-u.ac.jp
Received: December 8, 2020
Peer-review started: December 8, 2020
First decision: January 24, 2021
Revised: January 26, 2021
Accepted: March 11, 2021
Article in press: March 11, 2021
Published online: May 6, 2021
Processing time: 135 Days and 9.9 Hours
